iiinova — where your digital self keeps evolving

InSilicoMedChem ICR

@compchem-icr.bsky.social

In Silico Medicinal Chemistry at the Institute of Cancer Research 💻💊 Using computational chemistry to support projects within the Centre for Cancer Drug Discovery! 📍 London, UK

Posts Replies Media

InSilicoMedChem ICR @compchem-icr.bsky.social · 08/07/2026

We are looking for a Computational Chemist to join our Centre for Protein Degradation at the ICR @icr.ac.uk 📅 Application deadline: 31-July-2026 🔗 Learn more and apply here: jobs.icr.ac.uk/vacancies/15... #hiring #compchem #computationalchemistry #CADD #drugdiscovery #TPD #proteindegradation

jobs.icr.ac.uk

Computational Chemist in Sutton | The Institute of Cancer Research

View details and apply for this Computational Chemist vacancy in Sutton. Salary : £50,825 - £53,500 per annum. Commencement on the salary range is subject to comparable skills and experience...

023

Reposted by InSilicoMedChem ICR

Andrea Scarpino @andreascarpino.bsky.social · 30/08/2025

We're #hiring! 💻💊 Our @compchem-icr.bsky.social team is seeking to recruit a #postdoc to contribute to breakthrough cancer #drugdiscovery at @icr.ac.uk 📅 Application deadline: 12-September-2025 📍 Centre for Cancer Drug Discovery, Sutton, UK jobs.icr.ac.uk/vacancies/13... #CADD #compchem #cheminfo

jobs.icr.ac.uk

Postdoctoral Training Fellow - In Silico Medicinal Chemistry in Sutton | The Institute of Cancer Research

View details and apply for this Postdoctoral Training Fellow - In Silico Medicinal Chemistry vacancy in Sutton. Salary: Dependent on relevant Postdoctoral experience. Thi...

0109

InSilicoMedChem ICR @compchem-icr.bsky.social · 14/04/2025

Get your tickets now for two talks from ICR researchers in the division of Cancer Therapeutics, including one of our PhD students... #pint25

030

Reposted by InSilicoMedChem ICR

The Institute of Cancer Research @icr.ac.uk · 11/04/2025

NEWS: NICE has recommended capivasertib for advanced #BreastCancer. The decision makes the targeted drug available, in combination with fulvestrant, for some NHS patients with the most common type of breast cancer. Read more about the history of the drug⬇️ www.icr.ac.uk/about-us/icr...

0179